Back Dictionary Export CSV
Filter: Clear
ENCORE_PATIENT_ID MERGED_REGIMEN_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION BENCHMARK_GROUP LINK_NUMBER
20217588 20168747 1.77 66.5 Palliative (P) 2019-08-21 2019-08-22 IRINOTECAN + MDG + PANITUMUMAB 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101310422
20217593 20168748 1.55 56.25 Adjuvant (A) 2021-02-22 2021-02-24 EOX 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 100792392
20217594 20168749 1.76 58 Disease modification (D) 2018-06-23 2018-06-27 Sorafenib N N SORAFENIB 100818713
20217606 20168750 1.75 100.5 03 2019-05-01 2019-05-02 Capecitabine 35days + RT 02 N CAPECITABINE + RT 101774989
20217611 20168751 1.85 76.4 Curative (C) 2018-02-08 2018-02-10 Cetuximab + FLUOROURACIL + OXALIPLATIN 01 N CETUXIMAB + FLUOROURACIL + OXALIPLATIN 101813711
20217614 20168752 1.75 40.6 null 2018-04-15 2018-04-15 EOX 02 N EOX 101795127
20217617 20168753 1.62 53 Curative (C) 2016-09-25 2016-11-09 EOX 2 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 100543322
20217625 20168754 1.63 72.7 Palliative (P) 2017-05-26 2017-08-09 EOX N N TRIAL 100644966
20217626 20168755 1.75 68.1 Palliative (P) 2019-07-30 2019-08-13 EOX Y N CETUXIMAB + IRINOTECAN + MDG 100349850
20217630 20168756 1.7 58.8 Neo-adjuvant (N) 2016-05-20 2016-05-20 Capecitabine 35days + RT 02 Y CAPECITABINE + RT 101483077
20217635 20168757 1.76 60.3 Palliative (P) 2019-08-20 2019-08-20 CAPECITABINE + RT N N CAPECITABINE + RT 100564512
20217650 20168758 0 80.8 Neo-adjuvant (N) 2019-11-09 2019-12-14 Sorafenib 02 N SORAFENIB 101748297
20217654 20168759 1.75 108 Palliative (P) 2017-02-12 2018-05-01 Capecitabine 35days + RT N N CAPECITABINE + RT 100074409
20217655 20168760 1.79 77.5 Palliative (P) 2021-08-16 2021-08-16 CAPECITABINE + RT 02 N CAPECITABINE + RT 101732104
20217656 20168761 1.67 82.1 Neo-adjuvant (N) 2018-03-30 2018-05-03 EOX Y Y CETUXIMAB + IRINOTECAN + MDG 100091496
20217665 20168762 null null Palliative (P) 2016-06-08 2016-06-24 EOX 02 N EOX 100561873
20217690 20168763 1.83 63 03 2019-02-11 2019-03-21 EOX 02 Y CAPECITABINE + RT 100620826
20217702 20168764 1.85 102.2 null 2017-11-23 2017-11-24 Cetuximab + FOLFIRI cycle1 N null CETUXIMAB + IRINOTECAN + MDG 100297476
20217718 20168765 1.61 60 Palliative (P) 2019-11-07 2019-12-05 EOX 02 null EOX 101468388
20217724 20168766 1.83 59.2 null 2018-12-05 2018-12-05 Cetuximab + FOLFIRI cycle 2 onwards 02 N CETUXIMAB + IRINOTECAN + MDG 100290850
20217752 20168767 1.66 75.1 Adjuvant (A) 2018-03-02 2018-03-03 EOX N N CETUXIMAB + IRINOTECAN + MDG 101566733
20217761 20168768 1.69 72 Neo-adjuvant (N) 2020-01-25 2020-02-06 Sorafenib 02 Y SORAFENIB 101286693
20217775 20168769 1.84 88.7 Curative (C) 2018-10-30 2018-11-05 EOX 02 N SORAFENIB 101211440
20217781 20168770 1.79 60.8 null 2019-05-19 2019-06-02 IRINOTECAN + MDG + PANITUMUMAB 99 null FLUOROURACIL + IRINOTECAN + PANITUMUMAB 100499828
20217795 20168771 1.72 78.4 Palliative (P) 2018-02-27 2018-02-27 Cetuximab + FLUOROURACIL + OXALIPLATIN N N CETUXIMAB + FLUOROURACIL + OXALIPLATIN 100933505
20217816 20168772 1.54 99.5 Curative (C) 2021-03-19 2021-04-16 Trial Unspecified 2 N OXALIPLATIN + RALTITREXED 100592450
20217817 20168773 1.56 60 Palliative (P) 2017-01-07 2017-02-11 CAPECITABINE + RT N N CAPECITABINE + RT 100027642
20217818 20168774 0 58.8 Palliative (P) 2017-01-10 2017-02-02 EOX 02 N OXALIPLATIN + RALTITREXED 100290771
20217828 20168775 1.7 54.3 Neo-adjuvant (N) 2019-10-10 2019-10-11 EOX 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101285687
20217835 20168776 1.72 102 Palliative (P) 2021-08-06 2021-08-10 IRINOTECAN + MDG + PANITUMUMAB 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101687137
20217849 20168777 0 82.7 Palliative (P) 2021-05-01 2021-10-27 Cetuximab + FLUOROURACIL + OXALIPLATIN 02 N CETUXIMAB + FLUOROURACIL + OXALIPLATIN 100014071
20217859 20168778 1.76 109.8 Palliative (P) 2016-01-04 2016-04-29 EOX 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101433099
20217861 20168779 1.63 80 Palliative (P) 2017-02-28 2017-03-07 EOX 02 N CAPECITABINE + RT 101601494
20217869 20168780 1.64 47 Palliative (P) 2020-01-28 2020-02-08 Capecitabine 5days + RT 02 N CAPECITABINE + RT 100204204
20217887 20168781 1.7 76 Palliative (P) 2016-06-03 2016-06-03 CETUXIMAB + OXALIPLATIN + MDG 02 N CETUXIMAB + FLUOROURACIL + OXALIPLATIN 100091340
20217893 20168782 1.6 63.1 Palliative (P) 2018-03-03 2019-01-28 Sorafenib 02 N SORAFENIB 101581434
20217899 20168783 null 66 Palliative (P) 2019-05-24 2019-07-03 Cetuximab + FOLFIRI cycle 2 onwards 2 null CETUXIMAB + IRINOTECAN + MDG 100083245
20217922 20168784 1.84 47.6 Adjuvant (A) 2018-06-27 2018-07-18 IRINOTECAN + MDG + PANITUMUMAB 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 100148877
20217924 20168785 1.72 66.8 Palliative (P) 2018-03-28 2018-04-11 Sorafenib N N SORAFENIB 100222873
20217934 20168786 1.7 null Disease modification (D) 2015-08-08 2016-03-03 Trial Unspecified N Y TRIAL 101174738
20217948 20168787 1.75 102.2 Palliative (P) 2019-02-03 2019-02-12 EOX 02 null CAPECITABINE + RT 101581186
20217952 20168788 1.7 58 Palliative (P) 2019-01-18 2019-01-27 Oxaliplatin + Raltitrexed 02 N OXALIPLATIN + RALTITREXED 100406789
20217953 20168789 1.6 61.3 Palliative (P) 2019-03-04 2019-10-05 EOX N Y TRIAL 100016105
20217965 20168790 1.76 65 Palliative (P) 2019-08-28 2019-10-09 EOX 02 N CETUXIMAB + FLUOROURACIL + OXALIPLATIN 100148009
20217978 20168791 1.66 56.6 Neo-adjuvant (N) 2018-04-09 2018-05-07 EOX 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101677082
20217985 20168792 1.74 68.4 null 2016-03-17 2016-04-03 EOX N null TRIAL 101670572
20217987 20168793 null 65 Palliative (P) 2019-08-18 2019-08-22 EOX 02 null CETUXIMAB + FLUOROURACIL + OXALIPLATIN 101755936
20217989 20168794 1.76 76.7 Curative (C) 2017-07-11 2017-07-11 FLUOROURACIL + IRINOTECAN + PANITUMUMAB 2 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101038346
20217992 20168795 1.83 80.75 Palliative (P) 2019-03-27 2019-04-11 EOX 01 N TRIAL 101860127
20217993 20168796 1.55 49.5 Palliative (P) 2018-06-28 2018-07-16 Sorafenib 02 N SORAFENIB 100754645